ECSP055740A - Método para la obtención de líneas celulares en medio libre de proteína y líneas celulares obtenidas por este método. - Google Patents
Método para la obtención de líneas celulares en medio libre de proteína y líneas celulares obtenidas por este método.Info
- Publication number
- ECSP055740A ECSP055740A EC2005005740A ECSP055740A ECSP055740A EC SP055740 A ECSP055740 A EC SP055740A EC 2005005740 A EC2005005740 A EC 2005005740A EC SP055740 A ECSP055740 A EC SP055740A EC SP055740 A ECSP055740 A EC SP055740A
- Authority
- EC
- Ecuador
- Prior art keywords
- present
- grow
- protein
- free
- cells
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2803—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
- C07K16/2809—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against the T-cell receptor (TcR)-CD3 complex
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2863—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for growth factors, growth regulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2896—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against molecules with a "CD"-designation, not provided for elsewhere
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0693—Tumour cells; Cancer cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0693—Tumour cells; Cancer cells
- C12N5/0694—Cells of blood, e.g. leukemia cells, myeloma cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
- C12N2500/95—Protein-free medium and culture conditions
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
- C12N2510/02—Cells for production
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Engineering & Computer Science (AREA)
- Cell Biology (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
Abstract
La actual invención se relaciona con un método de obtención de células de mamífero adaptadas a crecer en medio libre de suero y proteínas, el procedimiento incluyen un proceso en dos etapas de adaptación para crecer en esa condición. La actual invención revela la existencia de un intervalo crítico de concentración de proteína en el cual las células deban crecer para ganar la capacidad de sobrevivir en medio libre de proteínas, una vez que las células hayan crecido en las concentraciones críticas del intervalo, las disminuciones subsiguientes de la concentración no afecten la viabilidad ni el tiempo de doblaje celular. El intervalo crítico de la concentración de la proteína es específico para cada línea celular.La presente invención también revela líneas celulares de mamíferos que crecen establemente en condiciones de medio libre de suero y proteínas por al menos 40 generaciones. Adicionalmente, los clones revelados en la presente invención expresan un producto recombinante.Los clones de la presente invención expresan los anticuerpos anti receptor de EGF hR3, el anti CD6 T1hT humanizados y el anticuerpo quimérico anti CD3 T3Q, además de los fragmentos de dichos anticuerpos.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CU20020239A CU23097A1 (es) | 2002-10-23 | 2002-10-23 | Método para la obtención de líneas celulares en medio libre de proteína y líneas celulares obtenidas por este método |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP055740A true ECSP055740A (es) | 2005-09-20 |
Family
ID=40134843
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EC2005005740A ECSP055740A (es) | 2002-10-23 | 2005-04-22 | Método para la obtención de líneas celulares en medio libre de proteína y líneas celulares obtenidas por este método. |
Country Status (27)
| Country | Link |
|---|---|
| US (2) | US20060036082A1 (es) |
| EP (2) | EP1564285B1 (es) |
| JP (1) | JP4674087B2 (es) |
| KR (1) | KR101186048B1 (es) |
| CN (1) | CN1714147B (es) |
| AR (1) | AR041645A1 (es) |
| AT (1) | ATE502103T1 (es) |
| AU (1) | AU2003273727B2 (es) |
| BR (1) | BR0315565B1 (es) |
| CA (1) | CA2503315C (es) |
| CU (1) | CU23097A1 (es) |
| DE (1) | DE60336415D1 (es) |
| DK (1) | DK1564285T3 (es) |
| EA (1) | EA007465B1 (es) |
| EC (1) | ECSP055740A (es) |
| ES (2) | ES2360049T3 (es) |
| GE (1) | GEP20084444B (es) |
| HR (1) | HRP20050760A2 (es) |
| LT (1) | LT5354B (es) |
| LV (1) | LV13361B (es) |
| MY (1) | MY144088A (es) |
| NZ (1) | NZ540171A (es) |
| PE (1) | PE20040552A1 (es) |
| PT (1) | PT1564285E (es) |
| TN (1) | TNSN05116A1 (es) |
| UY (1) | UY28037A1 (es) |
| WO (1) | WO2004038010A1 (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104673754B (zh) * | 2015-02-14 | 2018-03-02 | 百泰生物药业有限公司 | 重组骨髓瘤细胞克隆的筛选方法及由此获得的抗体分子 |
| CN104651314B (zh) * | 2015-02-14 | 2018-06-19 | 百泰生物药业有限公司 | 获得高产稳定表达细胞克隆的方法及由此获得的抗体分子 |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3694263A (en) * | 1970-10-23 | 1972-09-26 | Joseph J Korn Sr | Swimming pool cleaning methods and apparatus therefor |
| CU22545A1 (es) * | 1994-11-18 | 1999-03-31 | Centro Inmunologia Molecular | Obtención de un anticuerpo quimérico y humanizado contra el receptor del factor de crecimiento epidérmico para uso diagnóstico y terapéutico |
| US3886616A (en) * | 1972-12-06 | 1975-06-03 | Fay A Hayes | Hand propelled swimming pool cleaner |
| US4275474A (en) * | 1979-04-30 | 1981-06-30 | Woodard Randle C | Vacuum head for swimming pool cleaning system |
| US4240174A (en) * | 1979-07-30 | 1980-12-23 | Scott Jeffrey L | Self-contained mobile pool cleaning apparatus |
| US4430214A (en) * | 1982-09-15 | 1984-02-07 | Baker Marvin E | Strainer mill for swimming pool pump intake |
| AU2986484A (en) * | 1983-06-27 | 1985-01-03 | Monash University | Leptospira strains grown in protein free medium |
| US4558479A (en) * | 1984-01-26 | 1985-12-17 | Alopex Industries, Inc. | Pool cleaner |
| US4683599A (en) * | 1984-03-30 | 1987-08-04 | Fahet Nv | Automatic pool cleaner fitting |
| US4581075A (en) * | 1985-03-15 | 1986-04-08 | Maxi-Sweep, Inc. | Self-propelled water borne pool cleaner |
| DE69007291T2 (de) | 1989-09-29 | 1994-09-22 | Atomic Energy Of Canada Ltd | Infrarot-gasdetektor. |
| JP2696001B2 (ja) | 1991-04-15 | 1998-01-14 | 財団法人化学及血清療法研究所 | 組換え蛋白質産生用培地 |
| EP0531562A1 (de) | 1991-09-11 | 1993-03-17 | Doerr, Hans-Wilhelm, Prof. Dr. med. | Kultivierung von Säugetierzellen |
| AU707159B2 (en) * | 1994-09-16 | 1999-07-01 | Cancer Research Fund Of Contra Costa | Recombinant peptides derived from the Mc3 anti-BA46 antibody, methods of use thereof, and methods of humanizing antibody peptides |
| EP0791055B1 (en) | 1994-11-10 | 2012-01-25 | Baxter Healthcare S.A. | Method for producing biologicals in protein-free culture |
| AU703484B2 (en) | 1995-02-23 | 1999-03-25 | Quest International Services B.V. | Peptides for tissue and cell culture media |
| AUPN442295A0 (en) | 1995-07-26 | 1995-08-17 | Commonwealth Scientific And Industrial Research Organisation | Regulated autocrine growth of mammalian cells |
| CU22584A1 (es) | 1995-11-17 | 1999-11-03 | Centro Inmunologia Molecular | Composiciones farmacéuticas que contienen un anticuerpo monoclonal que reconoce el antígeno de diferenciación leucocitario humano cd6 y sus usos para el diagnóstico y tratamiento de la psoriasis |
| AT407255B (de) * | 1997-06-20 | 2001-02-26 | Immuno Ag | Rekombinanter zellklon mit erhöhter stabilität in serum- und proteinfreiem medium und verfahren zur gewinnung des stabilen zellklons |
-
2002
- 2002-10-23 CU CU20020239A patent/CU23097A1/es unknown
-
2003
- 2003-10-10 PE PE2003001035A patent/PE20040552A1/es not_active Application Discontinuation
- 2003-10-16 AR ARP030103776A patent/AR041645A1/es active IP Right Grant
- 2003-10-17 MY MYPI20033959A patent/MY144088A/en unknown
- 2003-10-22 EA EA200500695A patent/EA007465B1/ru not_active IP Right Cessation
- 2003-10-22 WO PCT/CU2003/000012 patent/WO2004038010A1/es not_active Ceased
- 2003-10-22 DK DK03757654.3T patent/DK1564285T3/da active
- 2003-10-22 HR HR20050760A patent/HRP20050760A2/xx not_active Application Discontinuation
- 2003-10-22 GE GEAP20038815A patent/GEP20084444B/en unknown
- 2003-10-22 CA CA2503315A patent/CA2503315C/en not_active Expired - Lifetime
- 2003-10-22 DE DE60336415T patent/DE60336415D1/de not_active Expired - Lifetime
- 2003-10-22 US US10/532,269 patent/US20060036082A1/en not_active Abandoned
- 2003-10-22 PT PT03757654T patent/PT1564285E/pt unknown
- 2003-10-22 ES ES03757654T patent/ES2360049T3/es not_active Expired - Lifetime
- 2003-10-22 AT AT03757654T patent/ATE502103T1/de active
- 2003-10-22 EP EP03757654A patent/EP1564285B1/en not_active Expired - Lifetime
- 2003-10-22 KR KR1020057006995A patent/KR101186048B1/ko not_active Expired - Lifetime
- 2003-10-22 CN CN2003801036918A patent/CN1714147B/zh not_active Expired - Lifetime
- 2003-10-22 NZ NZ540171A patent/NZ540171A/en not_active IP Right Cessation
- 2003-10-22 AU AU2003273727A patent/AU2003273727B2/en not_active Expired
- 2003-10-22 BR BRPI0315565A patent/BR0315565B1/pt active IP Right Grant
- 2003-10-22 EP EP11155076.0A patent/EP2363418B1/en not_active Expired - Lifetime
- 2003-10-22 JP JP2004545689A patent/JP4674087B2/ja not_active Expired - Lifetime
- 2003-10-22 ES ES11155076.0T patent/ES2624279T3/es not_active Expired - Lifetime
- 2003-10-23 UY UY28037A patent/UY28037A1/es not_active Application Discontinuation
-
2005
- 2005-04-22 TN TNP2005000116A patent/TNSN05116A1/en unknown
- 2005-04-22 EC EC2005005740A patent/ECSP055740A/es unknown
- 2005-05-19 LT LT2005053A patent/LT5354B/lt not_active IP Right Cessation
- 2005-05-23 LV LVP-05-61A patent/LV13361B/en unknown
-
2010
- 2010-04-13 US US12/759,208 patent/US20100197011A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Nguyen et al. | Extracellular vesicles in the intrauterine environment: challenges and potential functions | |
| ES2970817T3 (es) | Procedimientos para la inactivación vírica usando detergentes ecológicos | |
| CY1110695T1 (el) | Μεθοδοι για την δημιουργια υψηλου τιτλου ανευ-βοηθου παρασκευασματων απελευθερωμενων ανασυνδυασμενων aav φορεων | |
| DE502004008542D1 (de) | Verfahren zur reklonierung von produktionszellen | |
| CN110951673B (zh) | 一种利用小分子化合物体外诱导体细胞转分化为乳腺上皮细胞的方法 | |
| MX2008009220A (es) | Composiciones y metodos para la humanizacion y optimizacion de n-glicanos en plantas. | |
| CY1107689T1 (el) | Μεθοδοι και μεσα ελεγχου της σιαλιωσης πρωτεινων που παραγονται απο κυτταρα θηλαστικων | |
| MX2019010575A (es) | Metodo para producir anticuerpos multiespecificos. | |
| DE69126526D1 (de) | Verfahren zur zellwachstumshinderung und dazu nützliche verbindungen | |
| SA523451582B1 (ar) | Ccr8 الأجسام المضادة لـ | |
| CL2020002450A1 (es) | Glicoformas afucosiladas totales de anticuerpos producidos en cultivo celular | |
| ATE324030T1 (de) | Brassica-transformation durch teilchenbeschuss | |
| PL439807A1 (pl) | Sposoby oczyszczania przeciwciał i ich kompozycje | |
| CY1106111T1 (el) | Ανασυνδυασμενος σταθepος κυτταρικος κλωνος, η παρασκευη και χρησιμοποιηση του | |
| ECSP055740A (es) | Método para la obtención de líneas celulares en medio libre de proteína y líneas celulares obtenidas por este método. | |
| CU20170106A7 (es) | Método para obtener alto rendimiento de clones celulares de expresión estable | |
| Franke et al. | Mesenchymal–epithelial transitions: Spontaneous and cumulative syntheses of epithelial marker molecules and their assemblies to novel cell junctions connecting human hematopoietic tumor cells to carcinomatoid tissue structures | |
| CN108865995A (zh) | 促进脾脏来源的cd8阳性t细胞增殖的诱导培养组合物及其应用 | |
| JPH03254679A (ja) | 新規細胞株 | |
| Kitamura et al. | Adaptation of two mosquito cell lines to medium free of calf serum | |
| MX2023007302A (es) | Anticuerpos contra la integrina alfa 11 beta 1. | |
| Hohenwarter et al. | Human endothelial cell lines established by mutated forms of the simian virus 40 large T oncogene | |
| MX2016001041A (es) | Metodo para seleccionar una linea celular permisiva para replicar virus aviares. | |
| KR101348299B1 (ko) | Ｂｍｐ4 발현 세포를 무혈청 배지에서 단일클론으로 배양하는 방법 | |
| JP2004275047A (ja) | 無血清培養用培地 |